| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0002-9149(93)90732-R |
| P698 | PubMed publication ID | 8421977 |
| P50 | author | Trevor J. Orchard | Q30223717 |
| Lewis Kuller | Q88077314 | ||
| P2093 | author name string | Ferrell RE | |
| Eichner JE | |||
| Grandits GA | |||
| Neaton JD | |||
| McCallum LM | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myocardial infarction | Q12152 |
| P304 | page(s) | 160-165 | |
| P577 | publication date | 1993-01-01 | |
| P1433 | published in | American Journal of Cardiology | Q2208417 |
| P1476 | title | Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease | |
| P478 | volume | 71 |
| Q35040332 | A common copy number variation (CNV) polymorphism in the CNTNAP4 gene: association with aging in females |
| Q44794839 | A dietary and behavioral intervention designed to lower coronary heart disease. Risk factors are unaffected by variation at the APOE gene locus |
| Q40220422 | Apolipoprotein E alleles and sensorineural hearing loss |
| Q52013897 | Apolipoprotein E and Alzheimer's disease: the implications of progress in molecular medicine |
| Q33746638 | Apolipoprotein E and atherosclerosis: insight from animal and human studies |
| Q36819312 | Apolipoprotein E and change in episodic memory in blacks and whites |
| Q53251390 | Apolipoprotein E epsilon 4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease. |
| Q34809332 | Apolipoprotein E epsilon-4 polymorphism is associated with younger age at referral to a lipidology clinic and a poorer response to lipid-lowering therapy. |
| Q33735872 | Apolipoprotein E gene polymorphism and dyslipidaemia in adult Asian Indians: A population based study from Calcutta, India |
| Q36493730 | Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease |
| Q74476744 | Apolipoprotein E gene polymorphism in cerebrovascular disease: a case-control study |
| Q36023835 | Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease |
| Q43546731 | Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study |
| Q77925896 | Apolipoprotein E genotype and plasma levels in coronary artery disease. A case-control study in the Italian population |
| Q73193162 | Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy |
| Q35068761 | Apolipoprotein E polymorphism and atherosclerosis |
| Q73141437 | Apolipoprotein E polymorphism and carotid artery intima-media thickness in a random sample of middle-aged men |
| Q43645044 | Apolipoprotein E polymorphism and coronary disease |
| Q43734715 | Apolipoprotein E polymorphism and lipid levels differ by gender and family history of diabetes: the Rancho Bernardo Study |
| Q36688733 | Apolipoprotein E polymorphism in Italy investigated in native plasma by a simple polyacrylamide gel isoelectric focusing technique. Comparison with frequency data of other European populations |
| Q74176495 | Apolipoprotein E polymorphism in Northern Indian patients with coronary heart disease: phenotype distribution and relation to serum lipids and lipoproteins |
| Q36773237 | Apolipoprotein E ε4 allele interacts with sex and cognitive status to influence all-cause and cause-specific mortality in U.S. older adults |
| Q44129366 | Apolipoprotein E-epsilon 4 allele and familial risk in Alzheimer's disease |
| Q93109331 | Apolipoprotein E2 Genotype Is Associated with a 2-Fold Increase in the Incidence of Type 2 Diabetes Mellitus: Results from a Long-Term Observational Study |
| Q47892004 | Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins |
| Q45128303 | Apolipoprotein E4 Phenotype Is Not an Important Risk Factor for Coronary Heart Disease or Stroke in Elderly Subjects |
| Q44189963 | Apolipoprotein E4 forms a molten globule. A potential basis for its association with disease. |
| Q72267742 | Apolipoprotein epsilon 4 is not a genetic risk factor for coronary artery disease or restenosis after percutaneous transluminal coronary angioplasty |
| Q43864519 | Association of APOE epsilon2/epsilon3/epsilon4 and promoter gene variants with dementia but not cardiovascular mortality in old age. |
| Q57337171 | Association of apolipoprotein (Apo)E genotype with plasma apo E levels |
| Q36249248 | Atherosclerotic and thrombotic genetic and environmental determinants in Egyptian coronary artery disease patients: a pilot study. |
| Q24811731 | Cardiovascular damage in Alzheimer disease: autopsy findings from the Bryan ADRC. |
| Q34071528 | Common gene variants, mortality and extreme longevity in humans. |
| Q27624879 | Conformational flexibility in the apolipoprotein E amino-terminal domain structure determined from three new crystal forms: Implications for lipid binding |
| Q48700189 | Contributors to white matter damage in the frontal lobe in Alzheimer's disease |
| Q45985378 | Death certificate reporting of dementia and mortality in an Alzheimer's disease research center cohort. |
| Q34643186 | Diversity of apolipoprotein E genetic polymorphism significance on cardiovascular risk is determined by the presence of metabolic syndrome among hypertensive patients |
| Q35135403 | Do long-term HDL-C declines associated with a first birth vary by apo E phenotype? The Coronary Artery Risk Development in Young Adults (CARDIA) study |
| Q41307805 | Effect of age, ethnicity, and head injury on the association between APOE genotypes and Alzheimer's disease |
| Q73194210 | Effect of polymorphism of the endothelial nitric oxide synthase and apolipoprotein E genes on carotid atherosclerosis in hemodialysis patients |
| Q42130908 | Effects of the apolipoprotein E polymorphism on uptake and transfer of cell-derived cholesterol in plasma |
| Q34079609 | Epidemiology of dementia: concepts and overview |
| Q74190817 | Exercise-induced silent myocardial ischemia in master athletes |
| Q51985381 | Fuzzy set analyses of genetic determinants of health and disability status. |
| Q31709443 | Gene-diet interactions and plasma lipoproteins: role of apolipoprotein E and habitual saturated fat intake |
| Q28306136 | Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels |
| Q43591769 | Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia |
| Q34134818 | Genetic susceptibility factors for Alzheimer's disease. |
| Q35263448 | Genetic variants at the APOE, lipoprotein lipase (LpL), cholesteryl ester transfer protein (CETP), and endothelial nitric oxide (eNOS) genes and coronary artery disease (CAD): CETP Taq1 B2B2 associates with lower risk of CAD in Asian Indians |
| Q34189907 | Genetic variation in coronary heart disease and myocardial infarction: methodological overview and clinical evidence |
| Q74248771 | Genetic variations of the apolipoprotein E gene determine the plasma triglyceride levels after heart transplantation |
| Q35347421 | Genome-wide association study identifies a single major locus contributing to survival into old age; the APOE locus revisited |
| Q35960796 | Heart disease is common in humans and chimpanzees, but is caused by different pathological processes |
| Q33556143 | Heritabilities, apolipoprotein E, and effects of inbreeding on plasma lipids in a genetically isolated population: the Erasmus Rucphen Family Study |
| Q43284472 | Impact of ACE and ApoE polymorphisms on myocardial perfusion: correlation with myocardial single photon emission computed tomographic imaging |
| Q51574321 | Increased J774 macrophage cytotoxicity of late postprandial triglyceride-rich lipoproteins from normolipidemic young men expressing an apolipoprotein epsilon 4 allele. |
| Q35834286 | Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. |
| Q57417566 | Influence of apolipoprotein E polymorphism on serum lipid and lipoprotein changes: a 21-year follow-up study from childhood to adulthood. The Cardiovascular Risk in Young Finns Study |
| Q41712475 | Interaction of apolipoprotein E epsilon 4 with other genetic and non-genetic risk factors in late onset Alzheimer disease: problems facing the investigator |
| Q34785098 | Interactive effects of APOE haplotype, sex, and exercise on postheparin plasma lipase activities |
| Q33976938 | Interactive effects of apolipoprotein E type 4 genotype and cerebrovascular risk on neuropsychological performance and structural brain changes |
| Q74333547 | Is epsilon4 allele of apolipoprotein E associated with more severe end-organ damage in essential hypertension? |
| Q31817220 | Is the apoE4 allele an independent predictor of coronary events? |
| Q73739628 | Lack of association between variants of the angiotensinogen gene and the risk of coronary artery disease in middle-aged Japanese men |
| Q36485374 | Lack of association of apolipoprotein E (Apo E) polymorphism with the prevalence of metabolic syndrome: the National Heart, Lung and Blood Institute Family Heart Study |
| Q74561858 | Lack of interaction of apolipoprotein E phenotype with the lipoprotein response to lovastatin or gemfibrozil in patients with primary hypercholesterolemia |
| Q35751913 | Loss of apolipoprotein E exacerbates the neonatal lethality of the Smith-Lemli-Opitz syndrome mouse |
| Q35222771 | Meta-analysis of apolipoprotein E gene polymorphism and susceptibility of myocardial infarction |
| Q52034585 | Modeling the effects of genetic factors on late-onset diseases in cohort studies. |
| Q36192488 | Molecular determinants of human longevity |
| Q77482247 | Mortality differences by APOE genotype estimated from demographic synthesis |
| Q53215966 | NIA/AIzA Conference on apolipoprotein E genotyping in Alzheimer's disease. Bibliography. |
| Q41351424 | Observation of the density and size of cells in hippocampus and vascular lesion in thalamus of GFAP-apoE transgenic mice |
| Q34285979 | Pharmacogenomics: will it change the field of medicine? |
| Q46948459 | Protective effect of apolipoprotein E2 on coronary artery disease in African Americans is mediated through lipoprotein cholesterol |
| Q35881544 | Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. |
| Q26799413 | Role of apolipoprotein E in neurodegenerative diseases |
| Q37146359 | The Distribution of Apolipoprotein E Gene Polymorphism and Apolipoprotein E Levels among Coronary Artery Patients Compared to Controls |
| Q44247540 | The apolipoprotein E epsilon4 haplotype is an important predictor for recurrence in ischemic cerebrovascular disease |
| Q57337204 | The apolipoprotein E4 allele is not associated with an abnormal lipid profile in a Native American population following its traditional lifestyle |
| Q43805065 | The influence of apo E phenotypes on the plasma triglycerides response to hormonal replacement therapy during the menopause |
| Q33213990 | The key role of apolipoprotein E in atherosclerosis |
| Q73570846 | The next stage: molecular epidemiology |
| Q48397866 | The relationship between apolipoprotein E, dementia, and vascular illness. |
| Q35618918 | The role of cardiovascular risk factors in Alzheimer's disease |
| Q41161234 | The underlying molecular mechanism of apolipoprotein E polymorphism: relationships to lipid disorders, cardiovascular disease, and Alzheimer's disease. |
| Q47844521 | Transcriptional Effects of ApoE4: Relevance to Alzheimer's Disease |
| Q57502636 | What do we know about apolipoprotein E and the prevention of cardiovascular disease? |
Search more.